Nakshathra Medi Science Private Limited, a active private limited company, was established on 09 February 2021 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51909TN2021PTC141267. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Its leadership includes Beeraka Venkateswara Rao (Additional Director), Lakshmipathy Sugumaran (Additional Director), Nandhiyal Bharathi (Director). Past directors included Palaniappan Krishnan, Indhu, Thenappan. It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at No.21/21, Veerapandi Kattapomman Street, Ragavendra Salai, Chitlapakkam, Chennai, Tamil Nadu, 600064.
U51909TN2021PTC141267
141267
09 February 2021
₹1.50 M
₹1.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Nakshathra Medi Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Beeraka Venkateswara Rao | Additional Director | 21 Aug 2023 | Current |
| Lakshmipathy Sugumaran | Additional Director | 04 Mar 2023 | Current |
| Nandhiyal Bharathi | Director | 09 Feb 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Mar 2023 | Past |
| Pramod Abcsdd | Additional Director | 19 Oct 2024 | Past |
| Pramod Abcsdd | Additional Director | 26 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 26 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Mar 2023 | Past |
| Pramod Abcsdd | Additional Director | 21 Aug 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nakshathra Medi Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 85.56% decrease. The company also saw a substantial fall in profitability, with a 923.78% decrease in profit. The company's net worth observed a substantial decline by a decrease of 129.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nakshathra Medi Science had a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2023 | Canara Bank | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nakshathra Medi Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nakshathra Medi Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nakshathra Medi Science's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nakshathra Medi Science Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Beeraka Venkateswara Rao was appointed as a Additional Director was appointed as a Additional Director on 21 Aug 2023 & has been associated with this company since 2 years 3 months . was completed.
Progress on Nakshathra Medi Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai. was documented.
The activity Lakshmipathy Sugumaran was appointed as a Additional Director was appointed as a Additional Director on 04 Mar 2023 & has been associated with this company since 2 years 9 months . was completed.
A charge with Canara Bank amounted to Rs. 2.50 M with Charge ID 100685680 was registered on 08 Feb 2023. was recorded as a recent event.
Nandhiyal Bharathi was appointed as a Director was appointed as a Director on 09 Feb 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
The CIN of Nakshathra Medi Science Private Limited is U51909TN2021PTC141267.
Nakshathra Medi Science Private Limited is headquartered at No.21/21, Veerapandi Kattapomman Street, Ragavendra Salai, Chitlapakkam, Chennai, Tamil Nadu, 600064.
Nakshathra Medi Science Private Limited was incorporated on 09 February 2021.
The current directors of Nakshathra Medi Science Private Limited are
The primary industry of Nakshathra Medi Science Private Limited is Manufacturing.
Nakshathra Medi Science Private Limited is unlisted.
The authorized capital of Nakshathra Medi Science Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX